These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
332 related items for PubMed ID: 8380118
1. Increasing titers and changing specificities of antinuclear antibodies in patients with chronic liver disease who develop hepatocellular carcinoma. Imai H, Nakano Y, Kiyosawa K, Tan EM. Cancer; 1993 Jan 01; 71(1):26-35. PubMed ID: 8380118 [Abstract] [Full Text] [Related]
2. Nucleolar antigens and autoantibodies in hepatocellular carcinoma and other malignancies. Imai H, Ochs RL, Kiyosawa K, Furuta S, Nakamura RM, Tan EM. Am J Pathol; 1992 Apr 01; 140(4):859-70. PubMed ID: 1314027 [Abstract] [Full Text] [Related]
3. Diversity of antinuclear antibody responses in hepatocellular carcinoma. Covini G, von Mühlen CA, Pacchetti S, Colombo M, Chan EK, Tan EM. J Hepatol; 1997 Jun 01; 26(6):1255-65. PubMed ID: 9210612 [Abstract] [Full Text] [Related]
4. Investigation and analysis of HEp 2 indirect immunofluorescence titers and patterns in various liver diseases. Wei Q, Jiang Y, Xie J, Yang M, Zhang Y, Wu Z, Chen S, Liao Z, Lin Z, Gu J. Clin Rheumatol; 2020 Aug 01; 39(8):2425-2432. PubMed ID: 32103375 [Abstract] [Full Text] [Related]
5. Hepatitis B antigen and auto-antibodies in chronic liver diseases in Hong Kong. Lee AK. Aust N Z J Med; 1975 Jun 01; 5(3):235-9. PubMed ID: 169780 [Abstract] [Full Text] [Related]
6. Antibody detection using tumor-associated antigen mini-array in immunodiagnosing human hepatocellular carcinoma. Zhang JY, Megliorino R, Peng XX, Tan EM, Chen Y, Chan EK. J Hepatol; 2007 Jan 01; 46(1):107-14. PubMed ID: 17067715 [Abstract] [Full Text] [Related]
7. Identification of cyclin A as a molecular target of antinuclear antibodies (ANA) in hepatic and non-hepatic autoimmune diseases. Strassburg CP, Alex B, Zindy F, Gerken G, Lüttig B, Meyer zum Büschenfelde KH, Bréchot C, Manns MP. J Hepatol; 1996 Dec 01; 25(6):859-66. PubMed ID: 9007714 [Abstract] [Full Text] [Related]
8. Autoantibodies in Chinese patients with chronic hepatitis B: prevalence and clinical associations. Li BA, Liu J, Hou J, Tang J, Zhang J, Xu J, Song YJ, Liu AX, Zhao J, Guo JX, Chen L, Wang H, Yang LH, Lu J, Mao YL. World J Gastroenterol; 2015 Jan 07; 21(1):283-91. PubMed ID: 25574103 [Abstract] [Full Text] [Related]
9. Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile. Cassani F, Cataleta M, Valentini P, Muratori P, Giostra F, Francesconi R, Muratori L, Lenzi M, Bianchi G, Zauli D, Bianchi FB. Hepatology; 1997 Sep 07; 26(3):561-6. PubMed ID: 9303483 [Abstract] [Full Text] [Related]
10. [Investigation of antinuclear antibodies in chronic hepatitis B patients]. Şener AG, Aydın N, Ceylan C, Kırdar S. Mikrobiyol Bul; 2018 Oct 07; 52(4):425-430. PubMed ID: 30522427 [Abstract] [Full Text] [Related]
11. Detection of anti-LKM-1(anti-CYP2D6) by an enzyme-linked immunosorbent assay in adult patients with chronic liver diseases. Miyakawa H, Kikazawa E, Abe K, Kikuchi K, Fujikawa H, Matsushita M, Kawaguchi N, Morizane T, Ohya K, Kako M. Autoimmunity; 1999 Oct 07; 30(2):107-14. PubMed ID: 10435724 [Abstract] [Full Text] [Related]
12. Autoantibodies in viral hepatitis-related hepatocellular carcinoma. Imai H, Kiyosawa K, Chan EK, Tan EM. Intervirology; 1993 Oct 07; 35(1-4):73-85. PubMed ID: 8407252 [Abstract] [Full Text] [Related]
13. Immunogenicity of Ra1A and its tissue-specific expression in hepatocellular carcinoma. Wang K, Chen Y, Liu S, Qiu S, Gao S, Huang X, Zhang J, Peng X, Qiani W, Zhang JY. Int J Immunopathol Pharmacol; 2009 Oct 07; 22(3):735-43. PubMed ID: 19822090 [Abstract] [Full Text] [Related]
14. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases. Bayraktar Y, Bayraktar M, Gurakar A, Hassanein TI, Van Thiel DH. Hepatogastroenterology; 1997 Oct 07; 44(14):417-25. PubMed ID: 9164512 [Abstract] [Full Text] [Related]
15. Nuclear antigens reacted with sera and ascites of hepatocellular carcinoma patients. Chen YM, Hu CP, Chen PH, Chu MH, Tsai YT, Lee SD, Chang CM. Hepatology; 1988 Oct 07; 8(3):547-52. PubMed ID: 2836290 [Abstract] [Full Text] [Related]
16. Serum autoantibodies and the diagnosis of type-1 autoimmune hepatitis in Italy: a reappraisal at the light of hepatitis C virus infection. Cassani F, Muratori L, Manotti P, Lenzi M, Fusconi M, Ballardini G, Selleri L, Volta U, Zauli D, Miniero R. Gut; 1992 Sep 07; 33(9):1260-3. PubMed ID: 1330845 [Abstract] [Full Text] [Related]
17. Autoantibody responses in Chinese hepatocellular carcinoma. Zhang JY, Wang X, Peng XX, Chan EK. J Clin Immunol; 2002 Mar 07; 22(2):98-105. PubMed ID: 11998899 [Abstract] [Full Text] [Related]
18. A novel cytoplasmic protein with RNA-binding motifs is an autoantigen in human hepatocellular carcinoma. Zhang JY, Chan EK, Peng XX, Tan EM. J Exp Med; 1999 Apr 05; 189(7):1101-10. PubMed ID: 10190901 [Abstract] [Full Text] [Related]
19. Preneoplastic markers of hepatitis B virus-associated hepatocellular carcinoma. Hann HW, Lee J, Bussard A, Liu C, Jin YR, Guha K, Clayton MM, Ardlie K, Pellini MJ, Feitelson MA. Cancer Res; 2004 Oct 15; 64(20):7329-35. PubMed ID: 15492253 [Abstract] [Full Text] [Related]
20. Auto-antibodies in cirrhosis and hepatocellular carcinoma. Lee AK. Aust N Z J Med; 1973 Jun 15; 3(3):268-71. PubMed ID: 4354245 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]